BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1843882)

  • 21. [Clinical and pharmacokinetic evaluation of ofloxacin under various regimens of administration in patients with bronchopulmonary infections].
    Belousov OB; Gutkin AB; Sokolov AV; Tishchenkova IF; Efremenkova OV
    Antibiot Khimioter; 1996; 41(9):47-9. PubMed ID: 9005786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of cefazedon on patients with urinary tract infections (author's transl)].
    Lenzner A; Koch E
    Med Klin; 1979 May; 74(21):834-8. PubMed ID: 112365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of community-acquired pneumonia with ofloxacin.
    Youngchaiyud P; Permpikul C; Thamlikitkul V; Charoenratanakul S; Nana A
    J Med Assoc Thai; 1991 Feb; 74(2):61-5. PubMed ID: 2056259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ofloxacin in the management of complicated urinary tract infections, including prostatitis.
    Cox CE
    Am J Med; 1989 Dec; 87(6C):61S-68S. PubMed ID: 2690622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
    Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
    Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
    [No Abstract]   [Full Text] [Related]  

  • 26. Lincomycin in hospital practice.
    Duncan IB; Jeans B
    Can Med Assoc J; 1965 Sep; 93(13):685-91. PubMed ID: 5828940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
    Tauchnitz C
    Z Gesamte Inn Med; 1970 Aug; 25(16):734-8. PubMed ID: 4941224
    [No Abstract]   [Full Text] [Related]  

  • 28. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
    Barberán J; Aguilar L; Giménez MJ; Carroquino G; Granizo JJ; Prieto J
    Int J Antimicrob Agents; 2008 Aug; 32(2):154-7. PubMed ID: 18571387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
    Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
    Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral ofloxacin therapy for lower respiratory tract infection.
    Gentry LO; Lipsky B; Farber MO; Tucker B; Rodriguez-Gomez G
    South Med J; 1992 Jan; 85(1):14-8. PubMed ID: 1734527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Single day treatment in acute cystitis].
    Yamaguchi K; Kawaguchi K
    Hinyokika Kiyo; 1988 May; 34(5):811-3. PubMed ID: 3051939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of levofloxacin (DR-3355) on uro-genital infections--with special reference to usefulness for chronic prostatitis].
    Suzuki K; Horiba M
    Hinyokika Kiyo; 1992 Jun; 38(6):737-43. PubMed ID: 1632334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Staphylococcal infection of the deep respiratory tract. II. Relationship between the detection of staphylococci in the bronchial secretion and the clinical picture].
    Adler R; Bucher U
    Med Thorac; 1967; 24(4):255-68. PubMed ID: 6030888
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety in the oral treatment of purulent chest disease and pneumonia with cefixime, ofloxacin, and ciprofloxacin.
    Brückner O; Trautmann M
    J Chemother; 1989 Jul; 1(4 Suppl):782-3. PubMed ID: 16312637
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan.
    Shigemura K; Tanaka K; Okada H; Nakano Y; Kinoshita S; Gotoh A; Arakawa S; Fujisawa M
    Jpn J Infect Dis; 2005 Oct; 58(5):303-8. PubMed ID: 16249626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with parenteral and oral ofloxacin in severe infections.
    Kanellakopoulou K; Giamarellou H
    Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stepdown ofloxacin therapy in bronchopulmonary diseases].
    Nonikov VE; Lenkova NI; Makarova OV; Ritchik LA
    Antibiot Khimioter; 1996; 41(9):50-2. PubMed ID: 9005787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical safety and efficacy of ofloxacin.
    Marone P; Concia E; Grossi P; Malfitano A; Perversi L
    Chemioterapia; 1988 Oct; 7(5):320-2. PubMed ID: 3224401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Demethyl-vancomycin in treatment of resistant staphylococcal infections. A clinical evaluation].
    Zhu F
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):562-4, 575. PubMed ID: 1338524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.